key: cord-0696329-fnag7o48
authors: Finsterer, Josef; Scorza, Fulvio A.
title: SARS‐CoV‐2 myopathy
date: 2020-10-05
journal: J Med Virol
DOI: 10.1002/jmv.26550
sha: 0e25b69fd80b481107bcdf8c082507cadf6296d3
doc_id: 696329
cord_uid: fnag7o48

Since the occurrence of the first infection with SARS-CoV-2 in December 2019, increasing evidence accumulated that not only the lung but also other organs, including the central nervous system (CNS) and the peripheral nervous system (PNS), can be involved in the infection. This article is protected by copyright. All rights reserved.

To the Editor, Since the occurrence of the first infection with SARS-CoV-2 in December 2019, increasing evidence accumulated that not only the lung but also other organs, including the central nervous system and the peripheral nervous system (PNS), can be involved in the infection. Involvement of the PNS in SARS-CoV-2-infected patients includes Guillain-Barre syndrome, 1,2 myasthenia gravis (MG), 3,4 myositis, 5 myalgia, 6 rhabdomyolysis, 7-9 muscle wasting, and critical-ill myopathy. 10 Here we summarize and discuss recent findings concerning the involvement of the striated muscle in the infection. reporting the exact number. In a study of 27 pediatric patients with multisystem SARS-CoV-2 infection, four developed muscle weakness of whom three had a myogenic electromyography (EMG). All these studies did not mention how often muscle symptoms had been recognized already before the infection and none of these patients was prospectively investigated for primary or secondary muscle disease. 

The authors declare that there are no conflict of interests. 

Clinical neurophysiology and cerebrospinal liquor analysis to detect Guillain Barré syndrome and polyneuritis cranialis in COVID-19 patients: a case series

COVID-19 polyradiculitis in 24 patients without SARS-CoV-2 in the cerebro-spinal fluid

COVID-19 in patients with myasthenia gravis

COVID-19 and generalized myasthenia gravis exacerbation: a case report

COVID-19-associated myositis with severe proximal and bulbar weakness

Clinical features of patients infected with 2019 novel coronavirus in Wuhan

Rhabdomyolysis as an initial presentation in a patient diagnosed with COVID-19

Pediatric COVID-19-associated rhabdomyolysis: a case report

Rhabdomyolysis as potential late complication associated with COVID-19

Critical illness myopathy as a consequence of Covid-19 infection